Amneal Pharmaceuticals, Inc. AMRX United States — Long-Lived Assets
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The official record: Amneal Pharmaceuticals, Inc.’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s united states — long-lived assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s united states — long-lived assets?
- Amneal Pharmaceuticals, Inc. (AMRX) reported united states — long-lived assets of $313.51M in Q4 2025.
- How has Amneal Pharmaceuticals, Inc.'s united states — long-lived assets changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s united states — long-lived assets increased by 0.9% year-over-year, from $310.7M to $313.51M.
- What does united states — long-lived assets mean?
- This metric represents the total book value of non-current, tangible, and intangible assets physically located or legally domiciled within the United States. It reflects the company's capital investment in regional manufacturing facilities, distribution infrastructure, and localized intellectual property portfolios. Monitoring this balance helps investors assess the geographic concentration of production capacity and the scale of operational footprint within the domestic market.